MedTrace Logo

Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin

NCT03125668 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2020-03-30

No results posted yet for this study

Summary

The purpose of this study is to test an educational program with telephone follow-up to improve health-related quality of life (HRQoL), treatment adherence, and reduce anxiety and depression symptoms in patients who are starting oral anticoagulants (OA).

Conditions

  • Quality of Life
  • Warfarin
  • Health Education
  • Patient Compliance

Interventions

BEHAVIORAL

Educational Program

At the hospitalization, patients receive the educational program with Power Point®Slides, booklets and orientation about the use of warfarin.

BEHAVIORAL

Telephone follow-up

After hospital discharge they receive a telephone follow-up (five calls for six months: 1st call in one week and the others calls month by month until six months). During the telephone calls the researcher talk with the patient about the topics that were approach in the educational intervention and motivate the patient to follow the recommendations for they have a successful treatment.

BEHAVIORAL

Face to face counseling

They receive two face to face counseling (1st meeting in three months and the 2nd meeting in six months after hospital discharge). In the face to face counseling the researcher collect the data about anxiety and depression again, health-related quality of life and adverse events related to oral anticoagulation therapy.

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Rosana S Dantas, PhD · University of São Paulo at Ribeirão Preto College of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2017-05-30
Completion
2017-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03125668 on ClinicalTrials.gov